IQ healthcare, Radboud University and department of rheumatology Bernhoven

Research group IQ healthcare Radboud University and department of
Rheumatology, Bernhoven, The Netherlands.

This clinical research group has a track record in the assessment of inflammatory
rheumatic diseases. The Disease Activity Score was developed here, and is used
world-wide for the assessment of inflammatory activity in Rheumatoid Arthritis (RA).
Our research is directed at refinement of prognostic predictions, ‘tight control’
strategies for tailored treatment algorithms in rheumatoid arthritis, and understanding
patient and physician decision making processes. Major extra-articular
consequences of RA are fatigue and cardiovascular disease, in both we perform
research aimed at personalized treatment. Prediction of cardiovascular risk and
appropriate treatment of cardiovascular risk currently are the main topics of research
regarding rheumatoid arthritis and cardiovascular disease. In the past 5 years we are
also performing studies to improve self management of patients with RA, evaluate
the use of eHealth platforms and interventions to increase physical activity in patients
with rheumatic diseases.